mitochondria are the primary site for -oxidation of FAs
There is no business for Novo Nordisk in that area. Focus on obesity from the beginning (this is actually from ACQ2, a second podcast hosted by Gilbert and Rosenthal, in an episode focused on Knudsen): The target market was also obesity from the beginning, Knudsen says about GLP-1 molecules, pushing back on idea that they somehow stumbled into obesity
You pay after your IV is complete
Pregnancy while taking Retatrutide is contraindicated due to potential fetal development risks shown in animal studies
However, vitamins can sit unused for months, which raises the question of whether these vitamins actually expire and whether they remain effective over time
Rapid weight loss from GLP-1 therapy can lower estrogen levels, since estrogen is produced in fat tissue